Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Skin Neoplasms

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Skin Neoplasms in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanda, N1
Watanabe, S1
Duff, M1
Stapleton, PP1
Mestre, JR1
Maddali, S1
Smyth, GP1
Yan, Z1
Freeman, TA1
Daly, JM1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Skin Neoplasms

ArticleYear
Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:5

    Topics: Carcinoma, Squamous Cell; Chemokine CXCL10; Chemokines, CXC; Cyclic AMP; Cyclic AMP-Dependent Protei

2002
Cyclooxygenase-2 inhibition improves macrophage function in melanoma and increases the antineoplastic activity of interferon gamma.
    Annals of surgical oncology, 2003, Volume: 10, Issue:3

    Topics: Animals; Antineoplastic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibi

2003